InfuSystem
INFU
#8954
Rank
โ‚น18.11 B
Marketcap
โ‚น897.62
Share price
2.63%
Change (1 day)
75.32%
Change (1 year)

Revenue for InfuSystem (INFU)

Revenue in 2026 (TTM): โ‚น12.72 Billion

According to InfuSystem's latest financial reports the company's current revenue (TTM ) is โ‚น13.65 Billion. In 2025 the company made a revenue of โ‚น12.87 Billion an increase over the revenue in the year 2024 that were of โ‚น11.56 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for InfuSystem from 2008 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น12.72 B-1.14%
2025 โ‚น12.87 B11.3%
2024 โ‚น11.56 B10.48%
2023 โ‚น10.47 B15.13%
2022 โ‚น9.09 B19.36%
2021 โ‚น7.62 B6.99%
2020 โ‚น7.12 B23.13%
2019 โ‚น5.78 B23.22%
2018 โ‚น4.69 B3.44%
2017 โ‚น4.53 B-5.27%
2016 โ‚น4.79 B1.05%
2015 โ‚น4.74 B12.5%
2014 โ‚น4.21 B9.52%
2013 โ‚น3.84 B19.46%
2012 โ‚น3.22 B11.44%
2011 โ‚น2.89 B36.57%
2010 โ‚น2.11 B17.06%
2009 โ‚น1.80 B6.21%
2008 โ‚น1.70 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Premier
PINC
โ‚น96.33 B 605.39%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
โ‚น462.03 B 3,283.26%๐Ÿ‡บ๐Ÿ‡ธ USA
CorVel Corporation
CRVL
โ‚น91.92 B 573.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biolase
BIOL
โ‚น4.41 B-67.68%๐Ÿ‡บ๐Ÿ‡ธ USA